Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events - Additional Information (Detail)

v3.21.2
Subsequent Events - Additional Information (Detail)
1 Months Ended
Aug. 31, 2021
USD ($)
Takeda Development Agreement | Maximum | Forecast  
Subsequent Event [Line Items]  
Clinical milestone payments $ 22,250,000